
Primary Office
Temple Clinic
254-724-1713
Lucas Wong, M.D.
-
Principal Investigator, Community Clinical Oncology Program
-
Co-Director, Gastrointestinal Cancer Program
Gastrointestinal Cancer, Hematology and Oncology
Faculty Rank - Texas A&M Health Science Center College of Medicine
Associate Professor of Medicine
Education
- University of Texas Health Science Center at San Antonio, TX, M.D., 1988
- University of Texas at Austin, TX, B.S., 1984
Specialty Training
- Hematology/Oncology Fellowship, Arizona Cancer Center, University of Arizona Health Science Center, Tucson, AZ, 1991-1994
- Internal Medicine Internship and Residency, University of North Carolina Hospitals, Chapel Hill, NC, 1988-1991
Scott & White Appointment
July 18, 1994
Board Certification
American Board of Internal Medicine, Medical Oncology
Publications and Research
- Mishra R, Barthwal MK, Sondarva G, Rana B, Wong L, Chatterjee M, Woodgett JR, Rana A.
Glycogen Synthase Kinase-3 beta Induces Neuronal Cell Death via Direct Phosphorylation of Mixed Lineage Kinase-3. J Biol Chem. 2007 Oct 19;282(42):30393-405. Epub 2007 - Ochs AM, Wong L, Kakani V, Neerukonda S, Gorske J, Rao A, Riggs M, Ward H, Keville L.
Expression of vascular endothelial growth factor and HER2/neu in stage II colon cancer and correlation with survival. Clin.Colorectal Cancer 2004; 4[4]:262-267. - Sharma C, Pradeep A, Wong L, Rana A, Rana B.
PPARgamma activation can regulate beta -catenin levels via a proteasome mediated and APC independent pathway. Journal of Biological Chemistry 2004. - Rinehart J, Keville L, Neidhart J, Wong L, DiNunno L, Kinney P, Aberle M, Tadlock L, Cloud G.
Hematopoietic Protection by Dexamethasone or Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Patients Treated With Carboplatin and Ifosfamide. American Journal of Clinical Oncology 2003; 26[5]:448-458. - Cool RM, Herrington JD, Wong L.
Recurrent peripheral arterial thrombosis induced by cisplatin and etoposide. Pharmacotherapy 2002; 22[9]:1200-1204. - Wong L, Taylor CW, Radwanski E, Hersh EM, Salmon SE.
Comparison of 4- and 24-hour intravenous infusion schedules for granulocyte-macrophage colony-stimulating factor. J.Immunother.Emphasis.Tumor Immunol. 1995; 18[1]:57-65.
Professional Activities
-
Southwest Oncology Group Investigator
-
Member of Gastrointestinal Cancer Committee
-
National Surgical Adjuvant Breast and Bowel Project Investigator
-
Member of the Colorectal Cancer Committee
Awards
Upjohn Company Outstanding Oncology Fellow, 1994
Research & Education
Health Care Professionals
Patients